NCT00000938View on ClinicalTrials.gov

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

Not specified

Study Completion Date

November 30, 2005

Conditions
Lyme Disease
Interventions
DRUG

ceftriaxone

DRUG

doxycycline

Trial Locations (1)

02111

Mark Klempner, Boston

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000938 - A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease | Biotech Hunter | Biotech Hunter